CRNX / Crinetics Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Crinetics Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US22663K1079

Utestående aktier 94,175,994 shares
Insideraktier7 597 693 shares
Insynsägande8,07 %
Totalt antal insynspersoner39
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

-2 ( )

10283 out of 11305

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

-0.150 %( )

10678 out of 11224

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Crinetics Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
5AM Co-Investors IV, L.P. 10% Owner - [10%] 94 489 94 489
5AM Partners IV, LLC 10% Owner - [10%] 94 489 94 489
5AM Ventures IV, L.P. - 94 489 94 489
Camille L Bedrosian Director - [D] 16 300 16 300
Betz Stephen F. Chief Scientific Officer - [O] 99 713 99 713
John D Diekman 10% Owner - [10%] 94 489 94 489
Caren Deardorf Director - [D] 16 300 16 300
Joseph Edelman 10% Owner - [10%] 5 321 032 5 321 032
Matthew K Fust Director - [D] 28 836 28 836
James Hassard Chief Commercial Officer - [O] 29 259 29 259
Stephen W Kaldor 12 500
Knight Jeff E. Chief Operating Officer - [O] 87 491 87 491
Alan Seth Krasner Chief Medical Officer - [O] 43 210 43 210
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Ajay Madan Chief Development Officer - [O] 176 995 176 995
Weston Nichols Director - [D] 16 300 16 300
Jack Nielsen 12 500
Stephanie Okey Director - [D] 16 300 16 300
Perceptive Advisors Llc 10% Owner - [10%] 5 321 032 5 321 032
Perceptive Life Sciences Master Fund Ltd Director, 10% Owner - [D] [10%] 5 163 517 5 321 032
Dana Pizzuti Chief Med and Dev Officer - [O] 96 270 96 270
Scott M Rocklage 10% Owner - [10%] 94 489 94 489
Tobin Schilke Chief Financial Officer - [O] 52 000 52 000
Schwab Andrew J. 10% Owner - [10%] 94 489 94 489
Richard Scott Struthers President & CEO, Director - [D] [O] 661 205 661 205
Versant Affiliates Fund V, L.P. 10% Owner - [10%] 0 0
Versant Ophthalmic Affiliates I, L.P. 10% Owner - [10%] 0 0
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Versant Venture Capital V (Canada), LP 10% Owner - [10%] 0 0
Versant Venture Capital V, L.P. 10% Owner - [10%] 0 0
Versant Ventures V (Canada), L.P. 10% Owner - [10%] 0 0
Versant Ventures V, LLC 10% Owner - [10%] 0 0
Coelho Rogerio Vivaldi Director - [D] 21 300 21 300
Vivo Capital Fund VIII, L.P. 10% Owner - [10%] 298 625 298 625
Vivo Capital Surplus Fund VIII, L.P. 10% Owner - [10%] 298 625 298 625
Vivo Capital VIII, LLC 10% Owner - [10%] 298 625 298 625
Vivo Capital, LLC 10% Owner - [10%] 294 357 294 357
Vivo Opportunity Fund, L.P. 10% Owner - [10%] 168 165 168 165
Vivo Opportunity, LLC 10% Owner - [10%] 168 165 168 165
Wendall Wierenga Director - [D] 116 146 116 146
Marc Wilson CFO - [O] 111 565 111 565

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CRNX / Crinetics Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2023-06-08 Vivaldi Coelho Rogerio 5 000 22,0600 5 000 22,0600 110 300 343 51.9100 149 250 135,31
2022-04-18 PERCEPTIVE ADVISORS LLC 157 515 22,2200 157 515 22,2200 3 499 983
2021-10-25 PERCEPTIVE ADVISORS LLC 1 200 000 19,8000 1 200 000 19,8000 23 760 000
2021-04-08 PERCEPTIVE ADVISORS LLC 304 136 16,4400 304 136 16,4400 4 999 996
2020-12-03 Struthers Richard Scott 4 000 13,1000 4 000 13,1000 52 400
2020-12-02 Struthers Richard Scott 1 000 12,6000 1 000 12,6000 12 600
2020-04-17 PERCEPTIVE ADVISORS LLC 1 071 428 14,0000 1 071 428 14,0000 14 999 992
2018-07-20 PERCEPTIVE ADVISORS LLC 400 000 17,0000 400 000 17,0000 6 800 000
2018-07-20 5AM Ventures IV, L.P. 4 600 17,0000 4 600 17,0000 78 200

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

CRNX / Crinetics Pharmaceuticals, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CRNX / Crinetics Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2024-06-24 Pizzuti Dana 9 500 45,7300 9 500 45,7300 434 435 288 25.5600 −191 615 −44,11
2024-03-28 Okey Stephanie 17 500 46,3800 17 500 46,3800 811 650
2024-03-22 Knight Jeff E. 30 000 44,2200 30 000 44,2200 1 326 600
2024-03-22 Knight Jeff E. 2 359 45,3900 2 359 45,3900 107 075
2024-03-20 Pizzuti Dana 4 375 45,8900 4 375 45,8900 200 769
2024-03-20 Pizzuti Dana 10 000 43,2800 10 000 43,2800 432 800
2024-03-20 Pizzuti Dana 714 43,6900 714 43,6900 31 195
2023-12-21 Pizzuti Dana 9 583 34,5700 9 583 34,5700 331 284
2023-11-03 Struthers Richard Scott 199 082 30,5600 199 082 30,5600 6 083 946

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

CRNX / Crinetics Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-09-04 2025-09-02 4 Pizzuti Dana CRNX Common Stock S - Sale D 32,1000 −5 000 −160 96 270
2025-09-04 2025-09-02 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 5 000 84 101 270
2025-08-26 2025-08-22 4 Pizzuti Dana CRNX Common Stock S - Sale D 30,4300 −30 000 −913 66 270
2025-08-26 2025-08-22 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 30 000 507 96 270
2025-08-21 2025-08-20 4 Pizzuti Dana CRNX Common Stock S - Sale D 29,1800 −6 492 −189 66 270
2025-06-16 2025-06-12 4 Betz Stephen F. CRNX Common Stock S - Sale D 32,2300 −97 483 −3 142 99 713
2025-06-16 2025-06-12 4 Betz Stephen F. CRNX Common Stock M - Exercise D 9,2800 16 645 154 197 196
2025-06-16 2025-06-12 4 Betz Stephen F. CRNX Common Stock M - Exercise D 1,9100 71 525 137 180 551
2025-06-13 2025-06-11 4 Vivaldi Coelho Rogerio CRNX Common Stock A - Award D 6 900 21 300
2025-06-13 2025-06-11 4 Okey Stephanie CRNX Common Stock A - Award D 6 900 16 300
2025-06-13 2025-06-11 4 Deardorf Caren CRNX Common Stock A - Award D 6 900 16 300
2025-06-13 2025-06-11 4 WIERENGA WENDALL CRNX Common Stock A - Award D 6 900 116 146
2025-06-13 2025-06-11 4 Nichols Weston CRNX Common Stock A - Award D 6 900 16 300
2025-06-13 2025-06-11 4 Bedrosian Camille L CRNX Common Stock A - Award D 6 900 16 300
2025-06-13 2025-06-11 4 Fust Matthew K CRNX Common Stock A - Award D 6 900 28 836
2025-05-16 2025-05-14 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock G - Gift I 90 400 661 205
2025-05-16 2025-05-14 4 Struthers Richard Scott CRNX Common Stock G - Gift D −90 400 320 017
2025-04-04 2025-04-02 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 1,9100 81 270 155 410 417
2025-03-21 2025-03-19 4 Knight Jeff E. CRNX Common Stock S - Sale D 34,8300 −361 −13 87 491
2025-03-21 2025-03-19 4 Knight Jeff E. CRNX Common Stock S - Sale D 34,1700 −6 801 −232 87 852
2025-03-21 2025-03-19 4 Pizzuti Dana CRNX Common Stock S - Sale D 34,8300 −127 −4 72 233
2025-03-21 2025-03-19 4 Pizzuti Dana CRNX Common Stock S - Sale D 34,1700 −2 388 −82 72 360
2025-03-21 2025-03-19 4 Betz Stephen F. CRNX Common Stock S - Sale D 34,8300 −291 −10 108 588
2025-03-21 2025-03-19 4 Betz Stephen F. CRNX Common Stock S - Sale D 34,1700 −5 479 −187 108 879
2025-03-21 2025-03-19 4 Struthers Richard Scott CRNX Common Stock S - Sale D 34,8300 −875 −30 329 147
2025-03-21 2025-03-19 4 Struthers Richard Scott CRNX Common Stock S - Sale D 34,1700 −16 463 −563 330 022
2025-03-11 2025-03-10 4 Schilke Tobin CRNX Common Stock A - Award D 52 000 52 000
2025-02-24 2025-02-20 4 Betz Stephen F. CRNX Common Stock A - Award D 43 000 114 358
2025-02-24 2025-02-20 4 Pizzuti Dana CRNX Common Stock A - Award D 43 000 74 748
2025-02-24 2025-02-20 4 Knight Jeff E. CRNX Common Stock A - Award D 43 000 94 653
2025-02-24 2025-02-20 4 Struthers Richard Scott CRNX Common Stock A - Award D 89 000 346 485
2025-02-05 2025-02-03 4 Pizzuti Dana CRNX Common Stock S - Sale D 39,0700 −5 000 −195 31 748
2025-02-05 2025-02-03 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 5 000 84 36 748
2025-01-29 2024-11-20 5 Wilson Marc CRNX Common Stock J - Other D 14,9800 473 7 111 565
2025-01-29 2024-11-20 5 Betz Stephen F. CRNX Common Stock J - Other D 14,9800 451 7 71 358
2025-01-07 2025-01-07 4 Pizzuti Dana CRNX Common Stock M - Exercise D 19,6400 2 500 49 31 748
2025-01-07 2025-01-03 4 Pizzuti Dana CRNX Common Stock S - Sale D 52,0900 −15 000 −781 29 248
2025-01-07 2025-01-03 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 15 000 253 44 248
2024-12-18 2024-12-16 4 Betz Stephen F. CRNX Common Stock M - Exercise D 1,9100 2 331 4 71 358
2024-12-04 2024-12-02 4 Struthers Richard Scott By Family Trust 4 CRNX Common Stock S - Sale I 57,5700 −10 000 −576 100 000
2024-11-26 2024-11-22 4 Knight Jeff E. CRNX Common Stock S - Sale D 56,5200 −501 −28 51 653
2024-10-07 2024-10-03 4 Pizzuti Dana CRNX Common Stock S - Sale D 54,6300 −14 375 −785 28 507
2024-10-07 2024-10-03 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 14 375 243 42 882
2024-09-30 2024-09-26 4 Wilson Marc CRNX Common Stock S - Sale D 51,1100 −25 000 −1 278 111 092
2024-09-30 2024-09-26 4 Wilson Marc CRNX Common Stock M - Exercise D 15,2900 25 000 382 136 092
2024-09-12 2024-09-10 4 Betz Stephen F. CRNX Common Stock S - Sale D 51,5000 −1 035 −53 68 576
2024-08-28 2024-08-26 4 Betz Stephen F. CRNX Common Stock S - Sale D 53,1900 −3 000 −160 69 611
2024-08-14 2024-08-12 4 Betz Stephen F. CRNX Common Stock S - Sale D 47,6800 −3 000 −143 72 611
2024-07-26 2024-07-25 4 Betz Stephen F. CRNX Common Stock S - Sale D 53,4300 −3 000 −160 75 611
2024-07-26 2024-07-25 4 Wilson Marc CRNX Common Stock S - Sale D 53,8800 −19 056 −1 027 111 092
2024-07-26 2024-07-25 4 Wilson Marc CRNX Common Stock M - Exercise D 9,2800 19 056 177 130 148
2024-07-17 2024-07-15 4 Knight Jeff E. CRNX Common Stock S - Sale D 55,0000 −27 000 −1 485 51 653
2024-07-17 2024-07-15 4 Knight Jeff E. CRNX Common Stock M - Exercise D 19,6400 5 687 112 78 653
2024-07-17 2024-07-15 4 Knight Jeff E. CRNX Common Stock M - Exercise D 20,0200 2 887 58 72 966
2024-07-17 2024-07-15 4 Knight Jeff E. CRNX Common Stock M - Exercise D 23,9800 17 499 420 70 079
2024-07-17 2024-07-15 4 Wilson Marc CRNX Common Stock S - Sale D 55,0000 −25 000 −1 375 111 092
2024-07-17 2024-07-15 4 Wilson Marc CRNX Common Stock M - Exercise D 20,0200 25 000 500 136 092
2024-07-12 2024-07-10 4 Betz Stephen F. CRNX Common Stock S - Sale D 48,5500 −3 000 −146 78 611
2024-07-09 2024-07-05 4 Hassard James CRNX Common Stock S - Sale D 44,0800 −15 000 −661 29 259
2024-07-09 2024-07-05 4 Hassard James CRNX Common Stock M - Exercise D 19,7300 15 000 296 44 259
2024-07-05 2024-07-03 4 Pizzuti Dana CRNX Common Stock S - Sale D 44,8700 −14 375 −645 28 507
2024-07-05 2024-07-03 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 14 375 243 42 882
2024-07-02 2024-06-28 4 Wilson Marc CRNX Common Stock S - Sale D 43,6100 −32 129 −1 401 111 092
2024-07-02 2024-06-28 4 Wilson Marc CRNX Common Stock M - Exercise D 9,2800 32 129 298 143 221
2024-06-28 2024-06-26 4 Knight Jeff E. CRNX Common Stock S - Sale D 44,3800 −956 −42 52 580
2024-06-26 2024-06-25 4 Betz Stephen F. CRNX Common Stock S - Sale D 45,3700 −3 000 −136 80 643
2024-06-25 2024-06-24 4 Pizzuti Dana CRNX Common Stock S - Sale D 45,7300 −9 500 −434 27 786
2024-06-25 2024-06-24 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 9 500 160 37 286
2024-06-24 2024-06-21 4 Hassard James CRNX Common Stock S - Sale D 44,6600 −15 000 −670 29 259
2024-06-24 2024-06-21 4 Hassard James CRNX Common Stock M - Exercise D 19,7300 15 000 296 44 259
2024-06-11 2024-06-10 4 Betz Stephen F. CRNX Common Stock S - Sale D 43,8600 −3 000 −132 83 643
2024-06-11 2024-06-07 4 Deardorf Caren CRNX Common Stock A - Award D 3 400 9 400
2024-06-11 2024-06-07 4 Okey Stephanie CRNX Common Stock A - Award D 3 400 9 400
2024-06-11 2024-06-07 4 Vivaldi Coelho Rogerio CRNX Common Stock A - Award D 3 400 14 400
2024-06-11 2024-06-07 4 Fust Matthew K CRNX Common Stock A - Award D 3 400 21 936
2024-06-11 2024-06-07 4 Nichols Weston CRNX Common Stock A - Award D 3 400 9 400
2024-06-11 2024-06-07 4 WIERENGA WENDALL CRNX Common Stock A - Award D 3 400 109 246
2024-06-11 2024-06-07 4 Bedrosian Camille L CRNX Common Stock A - Award D 3 400 9 400
2024-05-30 2024-05-28 4 Betz Stephen F. CRNX Common Stock S - Sale D 47,4900 −3 000 −142 86 643
2024-05-14 2024-05-10 4 Betz Stephen F. CRNX Common Stock S - Sale D 49,4300 −3 000 −148 89 643
2024-05-10 2024-05-08 4 Struthers Richard Scott CRNX Common Stock S - Sale D 49,4000 −107 448 −5 308 257 485
2024-05-10 2024-05-08 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 9,2800 107 448 997 364 933
2024-04-22 2024-04-18 4 Struthers Richard Scott CRNX Common Stock G - Gift D −350 257 485
2024-04-17 2024-04-15 4 Pizzuti Dana CRNX Common Stock S - Sale D 44,4700 −14 375 −639 27 786
2024-04-17 2024-04-15 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 14 375 243 42 161
2024-04-17 2024-04-15 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 1,9100 20 000 38 257 835
2024-04-08 2024-04-04 4 Struthers Richard Scott CRNX Common Stock S - Sale D 49,1700 −40 951 −2 014 237 835
2024-04-08 2024-04-04 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 9,2800 40 951 380 278 786
2024-04-02 2024-03-28 4 Okey Stephanie CRNX Common Stock S - Sale D 46,3800 −17 500 −812 6 000
2024-04-02 2024-03-28 4 Okey Stephanie CRNX Common Stock M - Exercise D 18,2900 17 500 320 23 500
2024-03-26 2024-03-22 4 Knight Jeff E. CRNX Common Stock S - Sale D 45,3900 −2 359 −107 52 580
2024-03-26 2024-03-22 4 Knight Jeff E. CRNX Common Stock S - Sale D 44,2200 −30 000 −1 327 54 939
2024-03-26 2024-03-22 4 Knight Jeff E. CRNX Common Stock M - Exercise D 23,9800 30 000 719 84 939
2024-03-22 2024-03-20 4 Pizzuti Dana CRNX Common Stock S - Sale D 43,6900 −714 −31 27 786
2024-03-22 2024-03-20 4 Pizzuti Dana CRNX Common Stock S - Sale D 43,2800 −10 000 −433 28 500
2024-03-22 2024-03-20 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 10 000 169 38 500
2024-03-22 2024-03-20 4 Pizzuti Dana CRNX Common Stock S - Sale D 45,8900 −4 375 −201 28 500
2024-03-22 2024-03-20 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 4 375 74 32 875
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock S - Sale D 45,5000 −17 500 −796 18 536
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock M - Exercise D 18,2900 17 500 320 36 036
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock S - Sale D 43,5800 −17 500 −763 18 536
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock M - Exercise D 20,2300 17 500 354 36 036
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock S - Sale D 43,5700 −12 500 −545 18 536
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock S - Sale D 43,5700 −12 500 −545 18 536
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock M - Exercise D 23,2300 12 500 290 31 036
2024-03-22 2024-03-20 4 Fust Matthew K CRNX Common Stock M - Exercise D 23,2400 12 500 290 31 036
2024-03-20 2024-03-18 4 Pizzuti Dana CRNX Common Stock F - Taxes D 38,1400 −411 −16 28 500
2024-03-20 2024-03-18 4 Knight Jeff E. CRNX Common Stock F - Taxes D 38,1400 −4 283 −163 54 939
2024-03-20 2024-03-18 4 Betz Stephen F. CRNX Common Stock F - Taxes D 38,1400 −3 655 −139 92 643
2024-03-20 2024-03-18 4 Hassard James CRNX Common Stock F - Taxes D 38,1400 −1 741 −66 29 259
2024-03-20 2024-03-19 4 Wilson Marc CRNX Common Stock S - Sale D 42,9100 −6 942 −298 110 630
2024-03-20 2024-03-18 4 Wilson Marc CRNX Common Stock F - Taxes D 38,1400 −3 983 −152 117 572
2024-03-20 2024-03-18 4 Struthers Richard Scott CRNX Common Stock F - Taxes D 38,1400 −12 687 −484 237 835
2024-03-06 2024-03-04 4 Hassard James CRNX Common Stock A - Award D 17 000 31 000
2024-03-06 2024-03-04 4 Struthers Richard Scott CRNX Common Stock A - Award D 65 000 250 522
2024-03-06 2024-03-04 4 Wilson Marc CRNX Common Stock A - Award D 25 500 121 555
2024-03-06 2024-03-04 4 Pizzuti Dana CRNX Common Stock A - Award D 23 000 28 911
2024-03-06 2024-03-04 4 Knight Jeff E. CRNX Common Stock A - Award D 23 000 59 222
2024-03-06 2024-03-04 4 Betz Stephen F. CRNX Common Stock A - Award D 23 000 96 298
2024-02-14 2024-02-12 4 Struthers Richard Scott By Family Trust 2 CRNX Common Stock G - Gift I 20 000 110 000
2024-02-14 2024-02-12 4 Struthers Richard Scott By Family Trust 4 CRNX Common Stock G - Gift I 20 000 110 000
2024-02-14 2024-02-12 4 Struthers Richard Scott By Family Trust 3 CRNX Common Stock G - Gift I 20 000 110 000
2024-02-14 2024-02-12 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock G - Gift I −60 000 570 805
2024-02-12 2023-11-20 5 Knight Jeff E. CRNX Common Stock J - Other D 14,9800 931 14 36 222
2024-02-12 2023-05-22 5 Knight Jeff E. CRNX Common Stock J - Other D 14,9800 891 13 35 291
2024-01-26 2024-01-25 4 Betz Stephen F. CRNX Common Stock S - Sale D 37,2600 −3 000 −112 73 298
2024-01-12 2024-01-10 4 Betz Stephen F. CRNX Common Stock S - Sale D 37,6500 −3 000 −113 76 298
2024-01-04 2024-01-03 4 Pizzuti Dana CRNX Common Stock S - Sale D 35,0000 −14 375 −503 5 911
2024-01-04 2024-01-03 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 14 375 243 20 286
2024-01-04 2024-01-02 4 Wilson Marc CRNX Common Stock S - Sale D 35,4700 −10 000 −355 96 055
2024-01-04 2024-01-02 4 Wilson Marc CRNX Common Stock M - Exercise D 9,2800 10 000 93 106 055
2023-12-27 2023-12-26 4 Betz Stephen F. CRNX Common Stock S - Sale D 35,8900 −3 000 −108 79 298
2023-12-22 2023-12-21 4 Pizzuti Dana CRNX Common Stock S - Sale D 34,5700 −9 583 −331 5 911
2023-12-22 2023-12-21 4 Pizzuti Dana CRNX Common Stock M - Exercise D 16,8900 9 583 162 15 494
2023-12-13 2023-12-11 4 Betz Stephen F. CRNX Common Stock S - Sale D 32,8700 −3 000 −99 82 298
2023-11-29 2023-11-27 4 Betz Stephen F. CRNX Common Stock S - Sale D 31,8400 −3 000 −96 85 298
2023-11-13 2023-11-09 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 1,9100 50 000 96 185 522
2023-11-06 2023-11-03 4 Struthers Richard Scott CRNX Common Stock S - Sale D 30,5600 −199 082 −6 084 135 522
2023-11-06 2023-11-03 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 9,2800 199 082 1 847 334 604
2023-11-06 2023-11-02 4 Struthers Richard Scott CRNX Common Stock S - Sale D 29,9500 −918 −27 135 522
2023-11-06 2023-11-02 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 9,2800 918 9 136 440
2023-11-03 2023-11-01 4 Wilson Marc CRNX Common Stock S - Sale D 28,7500 −10 000 −288 95 601
2023-11-03 2023-11-01 4 Wilson Marc CRNX Common Stock M - Exercise D 9,2800 10 000 93 105 601
2023-10-19 2023-10-17 4 Krasner Alan Seth CRNX Common Stock S - Sale D 30,0000 −7 000 −210 43 210
2023-10-19 2023-10-17 4 Krasner Alan Seth CRNX Common Stock M - Exercise D 12,0100 7 000 84 50 210
2023-08-16 2023-08-14 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 1,9100 10 000 19 135 522
2023-07-13 2023-07-13 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 20,3500 −14 157 −288 630 805
2023-07-13 2023-07-12 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 20,1700 −11 459 −231 644 962
2023-07-13 2023-07-11 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 20,1400 −24 384 −491 656 421
2023-06-21 2023-06-16 4 Deardorf Caren CRNX Common Stock A - Award D 6 000 6 000
2023-06-21 2023-06-20 4 Wilson Marc CRNX Common Stock S - Sale D 19,9700 −20 000 −399 95 158
2023-06-21 2023-06-20 4 Wilson Marc CRNX Common Stock M - Exercise D 9,2800 20 000 186 115 158
2023-06-21 2023-06-20 4 Wilson Marc CRNX Common Stock S - Sale D 19,9600 −10 922 −218 95 158
2023-06-21 2023-06-16 4 Fust Matthew K CRNX Common Stock A - Award D 6 000 18 536
2023-06-21 2023-06-16 4 WIERENGA WENDALL CRNX Common Stock A - Award D 6 000 105 846
2023-06-21 2023-06-16 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 20,8100 −50 000 −1 040 680 805
2023-06-21 2023-06-16 4 Bedrosian Camille L CRNX Common Stock A - Award D 6 000 6 000
2023-06-21 2023-06-16 4 Vivaldi Coelho Rogerio CRNX Common Stock A - Award D 6 000 11 000
2023-06-21 2023-06-16 4 Okey Stephanie CRNX Common Stock A - Award D 6 000 6 000
2023-06-21 2023-06-16 4 Nichols Weston CRNX Common Stock A - Award D 6 000 6 000
2023-06-09 2023-06-08 4 Vivaldi Coelho Rogerio CRNX Common Stock P - Purchase D 22,0600 5 000 110 5 000
2023-04-05 2023-04-05 4 Pizzuti Dana CRNX Common Stock S - Sale D 16,1500 −8 212 −133 4 500
2023-04-05 2023-04-03 4 Pizzuti Dana CRNX Common Stock F - Taxes D 15,9800 −4 288 −69 12 712
2023-03-17 2023-03-16 4 Struthers Richard Scott CRNX Common Stock F - Taxes D 17,1200 −4 628 −79 125 522
2023-03-17 2023-03-16 4 Wilson Marc CRNX Common Stock F - Taxes D 17,1200 −1 666 −29 106 080
2023-03-17 2023-03-16 4 Knight Jeff E. CRNX Common Stock F - Taxes D 17,1200 −587 −10 34 400
2023-03-17 2023-03-16 4 Krasner Alan Seth CRNX Common Stock F - Taxes D 17,1200 −1 687 −29 42 301
2023-03-17 2023-03-16 4 Betz Stephen F. CRNX Common Stock F - Taxes D 17,1200 −1 410 −24 86 879
2023-03-03 2023-03-01 4 Hassard James CRNX Common Stock A - Award D 14 000 14 000
2023-03-03 2023-03-01 4 Krasner Alan Seth CRNX Common Stock A - Award D 19 500 43 988
2023-03-03 2023-03-01 4 Pizzuti Dana CRNX Common Stock A - Award D 4 500 17 000
2023-03-03 2023-03-01 4 Betz Stephen F. CRNX Common Stock A - Award D 23 600 88 289
2023-03-03 2023-03-01 4 Knight Jeff E. CRNX Common Stock A - Award D 29 500 34 987
2023-03-03 2023-03-01 4 Wilson Marc CRNX Common Stock A - Award D 24 200 107 746
2023-03-03 2023-03-01 4 Struthers Richard Scott CRNX Common Stock A - Award D 61 650 130 150
2023-02-03 2023-02-01 4 Betz Stephen F. CRNX Common Stock S - Sale D 19,5900 −3 126 −61 64 689
2023-01-27 2022-11-20 5 Krasner Alan Seth CRNX Common Stock J - Other D 11,0200 712 8 24 488
2023-01-27 2022-05-20 5 Krasner Alan Seth CRNX Common Stock J - Other D 11,0200 1 215 13 23 776
2023-01-27 2022-11-20 5 Wilson Marc CRNX Common Stock J - Other D 11,0200 482 5 83 546
2023-01-27 2022-05-20 5 Wilson Marc CRNX Common Stock J - Other D 11,0200 1 446 16 83 064
2023-01-27 2023-01-25 4 Betz Stephen F. CRNX Common Stock S - Sale D 21,0700 −8 336 −176 67 815
2023-01-27 2022-11-20 5 Knight Jeff E. CRNX Common Stock J - Other D 15,1600 537 8 5 487
2023-01-19 2023-01-17 4 Betz Stephen F. CRNX Common Stock S - Sale D 18,0000 −3 126 −56 76 151
2023-01-05 2023-01-03 4 Betz Stephen F. CRNX Common Stock S - Sale D 18,3500 −3 126 −57 79 277
2022-12-19 2022-12-15 4 Betz Stephen F. CRNX Common Stock S - Sale D 16,0000 −3 126 −50 82 403
2022-12-05 2022-12-01 4 Betz Stephen F. CRNX Common Stock S - Sale D 17,8400 −3 126 −56 84 968
2022-11-17 2022-11-15 4 Betz Stephen F. CRNX Common Stock S - Sale D 18,7200 −3 126 −59 88 094
2022-11-03 2022-11-01 4 Betz Stephen F. CRNX Common Stock S - Sale D 18,5200 −3 126 −58 91 220
2022-10-19 2022-10-17 4 Betz Stephen F. CRNX Common Stock S - Sale D 17,7300 −3 126 −55 94 346
2022-10-14 2022-10-12 4 Struthers Richard Scott CRNX Common Stock M - Exercise D 1,9100 11 100 21 68 500
2022-10-11 2022-10-10 4 Pizzuti Dana CRNX Common Stock A - Award D 12 500 12 500
2022-10-05 2022-10-03 4 Betz Stephen F. CRNX Common Stock S - Sale D 19,6400 −3 126 −61 97 472
2022-09-19 2022-09-15 4 Betz Stephen F. CRNX Common Stock S - Sale D 21,0100 −4 168 −88 100 598
2022-09-09 2022-09-07 4 Betz Stephen F. CRNX Common Stock S - Sale D 21,0017 −1 042 −22 104 766
2022-09-06 2022-09-01 4 Betz Stephen F. CRNX Common Stock S - Sale D 18,5900 −3 126 −58 105 808
2022-09-06 2022-05-20 4 Betz Stephen F. CRNX Common Stock J - Other D 11,0200 1 336 15 108 934
2022-07-29 2022-07-26 4 Knight Jeff E. CRNX Common Stock S - Sale D 20,7004 −1 152 −24 4 950
2022-07-29 2022-05-20 4 Knight Jeff E. CRNX Common Stock J - Other D 17,4400 1 152 20 6 102
2022-07-15 2022-07-13 4 Fust Matthew K CRNX Common Stock S - Sale D 20,9570 −5 700 −119 12 536
2022-07-15 2022-07-13 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,4500 5 700 8 18 236
2022-05-04 2022-05-02 4 Betz Stephen F. CRNX Common Stock S - Sale D 20,0960 −3 247 −65 107 598
2022-04-21 2022-04-18 4 Betz Stephen F. CRNX Common Stock S - Sale D 25,8100 −5 664 −146 110 845
2022-04-18 2022-04-18 4 PERCEPTIVE ADVISORS LLC CRNX Common Stock P - Purchase I 22,2200 157 515 3 500 5 321 032
2022-04-15 2022-04-13 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 27,5277 −69 176 −1 904 730 805
2022-04-15 2022-04-13 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 26,5229 −44 793 −1 188 799 981
2022-04-15 2022-04-13 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 25,4247 −24 674 −627 844 774
2022-04-07 2022-04-05 4 Struthers Richard Scott By Family Trust 1 CRNX Common Stock S - Sale I 25,3418 −21 357 −541 869 448
2022-04-06 2022-04-04 4 Betz Stephen F. CRNX Common Stock S - Sale D 23,9735 −9 000 −216 116 509
2022-04-04 2022-01-03 4/A Vivaldi Coelho Rogerio CRNX Stock Option (right to buy) A - Award D 28,31 35 000 35 000
2022-04-04 2022-03-11 4/A Deardorf Caren CRNX Stock Option (right to buy) A - Award D 19,30 35 000 35 000
2022-04-01 2022-04-01 4 Betz Stephen F. CRNX Common Stock S - Sale D 21,8000 −4 164 −91 125 509
2022-04-01 2022-03-31 4 Betz Stephen F. CRNX Common Stock S - Sale D 21,0614 −4 164 −88 129 673
2022-03-17 2022-03-15 4 Betz Stephen F. CRNX Common Stock S - Sale D 18,9400 −3 123 −59 133 837
2022-03-14 2022-03-11 4 Deardorf Caren CRNX Stock Option (right to buy) A - Award D 19,30 25 000 25 000
2022-03-10 2022-03-10 4 Hassard James CRNX Stock Option (right to buy) A - Award D 19,73 160 000 160 000
2022-03-02 2022-02-28 4 Knight Jeff E. CRNX Stock Option (right to buy) A - Award D 20,02 23 100 23 100
2022-03-02 2022-02-28 4 Knight Jeff E. CRNX Common Stock A - Award D 4 950 4 950
2022-03-02 2022-02-28 4 Struthers Richard Scott CRNX Common Stock (right to buy) A - Award D 20,02 249 200 249 200
2022-03-02 2022-02-28 4 Struthers Richard Scott CRNX Common Stock A - Award D 53 400 57 400
2022-03-02 2022-02-28 4 Wilson Marc CRNX Stock Option (right to buy) A - Award D 20,02 91 000 91 000
2022-03-02 2022-02-28 4 Wilson Marc CRNX Common Stock A - Award D 19 500 81 618
2022-03-02 2022-02-28 4 Krasner Alan Seth CRNX Common Stock (right to buy) A - Award D 20,02 66 500 66 500
2022-03-02 2022-02-28 4 Krasner Alan Seth CRNX Common Stock A - Award D 14 250 22 561
2022-03-02 2022-03-01 4 Betz Stephen F. CRNX Common Stock S - Sale D 19,7300 −3 123 −62 136 960
2022-03-02 2022-02-28 4 Betz Stephen F. CRNX Stock Option (right to buy) A - Award D 20,02 77 000 77 000
2022-03-02 2022-02-28 4 Betz Stephen F. CRNX Common Stock A - Award D 16 500 140 083
2022-03-02 2022-03-01 4 Madan Ajay CRNX Common Stock S - Sale D 19,8800 9 000 179 176 995
2022-03-02 2022-02-28 4 Madan Ajay CRNX Common Stock (right to buy) A - Award D 20,02 65 400 65 400
2022-03-02 2022-02-28 4 Madan Ajay CRNX Common Stock A - Award D 13 950 185 995
2022-02-17 2022-02-15 4 Betz Stephen F. CRNX Common stock S - Sale D 18,6400 −3 123 −58 123 583
2022-02-09 2022-02-07 4 Madan Ajay CRNX Common Stock S - Sale D 17,8275 −13 411 −239 172 045
2022-02-04 2021-11-19 5 Wilson Marc CRNX Common Stock J - Other D 11,0200 837 9 62 118
2022-02-04 2021-05-20 5 Wilson Marc CRNX Common Stock J - Other D 11,0200 1 090 12 61 281
2022-02-04 2021-11-19 5 Madan Ajay CRNX Common Stock J - Other D 11,0200 785 9 185 456
2022-02-03 2022-02-01 4 Betz Stephen F. CRNX Common stock S - Sale D 18,7900 −3 123 −59 126 706
2022-01-21 2022-01-19 4 Krasner Alan Seth CRNX Non-qualified stock option (Right to Buy) M - Exercise D 12,01 −6 700 160 473
2022-01-21 2022-01-19 4 Krasner Alan Seth CRNX Common Stock S - Sale D 21,2060 −6 700 −142 8 311
2022-01-21 2022-01-19 4 Krasner Alan Seth CRNX Common Stock M - Exercise D 12,0100 6 700 80 15 011
2022-01-20 2022-01-18 4 Betz Stephen F. CRNX Common stock S - Sale D 23,2900 −4 168 −97 128 875
2022-01-10 2022-01-03 4 Vivaldi Coelho Rogerio CRNX Stock Option (right to buy) A - Award D 28,31 25 000 25 000
2022-01-06 2022-01-03 4 Betz Stephen F. CRNX Common stock S - Sale D 28,0200 −7 168 −201 133 043
2021-12-30 2021-12-28 4 Betz Stephen F. CRNX Common stock S - Sale D 27,9506 −3 000 −84 140 211
2021-12-17 2021-12-15 4 Betz Stephen F. CRNX Common stock S - Sale D 24,1400 −5 668 −137 143 211
2021-12-03 2021-12-01 4 Betz Stephen F. CRNX Common stock S - Sale D 27,3800 −5 668 −155 148 879
2021-11-17 2021-11-16 4 Betz Stephen F. CRNX Common Stock S - Sale D 27,9700 −1 500 −42 154 547
2021-11-17 2021-11-15 4 Betz Stephen F. CRNX Common stock S - Sale D 26,7500 −5 668 −152 156 047
2021-11-09 2021-11-08 4 Betz Stephen F. CRNX Common stock S - Sale D 28,4220 −3 900 −111 161 715
2021-11-09 2021-11-05 4 Betz Stephen F. CRNX Common stock S - Sale D 27,9520 −12 600 −352 165 615
2021-11-03 2021-11-01 4 Betz Stephen F. CRNX Common stock S - Sale D 24,7900 −5 668 −141 178 215
2021-11-03 2021-11-01 4 Fust Matthew K CRNX Non-qualified stock option (Right to Buy) M - Exercise D 1,91 −8 954 12 092
2021-11-03 2021-11-01 4 Fust Matthew K CRNX Common Stock S - Sale D 25,5000 −8 954 −228 12 536
2021-11-03 2021-11-01 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,9100 8 954 17 21 490
2021-11-01 2021-10-28 4 Madan Ajay CRNX Stock Option (right to buy) M - Exercise D 0,73 −106 383 0
2021-11-01 2021-10-28 4 Madan Ajay CRNX Common Stock M - Exercise D 0,7300 106 383 78 184 671
2021-10-28 2021-10-27 4 Betz Stephen F. CRNX Common stock S - Sale D 23,9970 −3 000 −72 183 883
2021-10-25 2021-10-21 4 Betz Stephen F. CRNX Common stock S - Sale D 21,0975 −1 042 −22 186 883
2021-10-25 2021-10-25 4 PERCEPTIVE ADVISORS LLC CRNX Common Stock P - Purchase I 19,8000 1 200 000 23 760 5 163 517
2021-10-19 3 Betz Stephen F. CRNX Common Stock D 187 925
2021-09-09 2021-09-07 4 Struthers Richard Scott By Family Trust 2 CRNX Common stock S - Sale I 25,0000 −10 000 −250 90 000
2021-09-09 2021-09-07 4 Struthers Richard Scott By Family Trust 4 CRNX Common stock S - Sale I 25,0000 −10 000 −250 90 000
2021-09-09 2021-09-07 4 Struthers Richard Scott By Family Trust 3 CRNX Common stock S - Sale I 25,0000 −10 000 −250 90 000
2021-09-09 2021-09-08 4 Fust Matthew K CRNX Non-qualified stock option (Right to Buy) M - Exercise D 1,91 −6 046 21 046
2021-09-09 2021-09-08 4 Fust Matthew K CRNX Common Stock S - Sale D 25,5000 −6 046 −154 12 536
2021-09-09 2021-09-08 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,9100 6 046 12 18 582
2021-09-02 2021-09-01 4 Knight Jeff E. CRNX Stock Option (right to buy) A - Award D 23,98 160 000 160 000
2021-07-27 2021-07-26 4 Fust Matthew K CRNX Non-qualified stock option (Right to Buy) M - Exercise D 1,91 −5 000 27 092
2021-07-27 2021-07-26 4 Fust Matthew K CRNX Common Stock S - Sale D 19,5900 −5 000 −98 12 536
2021-07-27 2021-07-26 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,9100 5 000 10 17 536
2021-07-20 2021-07-19 4 Fust Matthew K CRNX Non-qualified stock option (Right to Buy) M - Exercise D 1,91 −5 000 32 092
2021-07-20 2021-07-19 4 Fust Matthew K CRNX Common Stock S - Sale D 19,5000 −5 000 −98 12 536
2021-07-20 2021-07-19 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,9100 5 000 10 17 536
2021-07-13 2021-07-12 4 Fust Matthew K CRNX Non-qualified stock option (Right to Buy) M - Exercise D 1,91 −5 000 37 092
2021-07-13 2021-07-12 4 Fust Matthew K CRNX Common Stock S - Sale D 20,7100 −5 000 −104 12 536
2021-07-13 2021-07-12 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,9100 5 000 10 17 536
2021-06-23 2021-06-22 4 Fust Matthew K CRNX Stock Option (right to buy) A - Award D 20,23 17 500 17 500
2021-06-23 2021-06-22 4 Nichols Weston CRNX Stock Option (right to buy) A - Award D 20,23 17 500 17 500
2021-06-23 2021-06-22 4 Bedrosian Camille L CRNX Stock Option (right to buy) A - Award D 20,23 17 500 17 500
2021-06-23 2021-06-22 4 Okey Stephanie CRNX Stock Option (right to buy) A - Award D 20,23 17 500 17 500
2021-06-23 2021-06-22 4 WIERENGA WENDALL CRNX Stock Option (right to buy) A - Award D 20,23 17 500 17 500
2021-04-09 2021-04-08 4 PERCEPTIVE ADVISORS LLC CRNX Common Stock P - Purchase I 16,4400 304 136 5 000 3 963 517
2021-03-02 2021-02-26 4 Struthers Richard Scott CRNX Stock Option (right to buy) A - Award D 15,29 294 000 294 000
2021-03-02 2021-02-26 4 Wilson Marc CRNX Stock Option (right to buy) A - Award D 15,29 114 000 114 000
2021-03-02 2021-02-26 4 Madan Ajay CRNX Stock Option (right to buy) A - Award D 15,29 131 000 131 000
2021-03-02 2021-02-26 4 Krasner Alan Seth CRNX Stock Option (right to buy) A - Award D 15,29 125 000 125 000
2021-02-05 2020-11-20 5 Wilson Marc CRNX Common Stock J - Other D 11,6100 702 8 60 191
2021-02-05 2020-05-20 5 Wilson Marc CRNX Common Stock J - Other D 14,4500 697 10 59 489
2021-02-05 2020-11-20 5 Krasner Alan Seth CRNX Common Stock J - Other D 11,6100 277 3 6 383
2021-02-05 2020-05-20 5 Krasner Alan Seth CRNX Common Stock J - Other D 14,4500 1 165 17 6 106
2021-02-05 2020-05-20 5 Madan Ajay CRNX Common Stock J - Other D 14,4500 1 470 21 77 516
2020-12-04 2020-12-03 4 Struthers Richard Scott CRNX Common stock P - Purchase D 13,1000 4 000 52 4 000
2020-12-04 2020-12-02 4 Struthers Richard Scott By Spouse CRNX Common stock P - Purchase I 12,6000 1 000 13 1 000
2020-09-03 2020-09-01 4 Bedrosian Camille L CRNX Stock Option (right to buy) A - Award D 16,08 25 000 25 000
2020-07-17 2020-07-16 4 Struthers Richard Scott By Family Trust 1 CRNX Common stock S - Sale I 14,4633 −17 500 −253 890 805
2020-07-17 2020-07-15 4 Struthers Richard Scott By Family Trust 1 CRNX Common stock S - Sale I 15,2984 −17 500 −268 908 305
2020-06-22 2020-06-19 4 WIERENGA WENDALL CRNX Stock Option (right to buy) A - Award D 23,23 12 500 12 500
2020-06-22 2020-06-19 4 Okey Stephanie CRNX Stock Option (right to buy) A - Award D 23,23 12 500 12 500
2020-06-22 2020-06-19 4 Nichols Weston CRNX Stock Option (right to buy) A - Award D 23,23 12 500 12 500
2020-06-22 2020-06-19 4 Kaldor Stephen W CRNX Stock Option (right to buy) A - Award D 23,23 12 500 12 500
2020-06-22 2020-06-19 4 Fust Matthew K CRNX Stock Option (right to buy) A - Award D 23,23 12 500 12 500
2020-04-29 2020-04-28 4 WIERENGA WENDALL CRNX Stock Option (right to but) M - Exercise D 0,73 −25 329 12 500
2020-04-29 2020-04-28 4 WIERENGA WENDALL CRNX Common Stock M - Exercise D 0,7300 25 329 18 99 846
2020-04-20 2020-04-17 4 PERCEPTIVE ADVISORS LLC CRNX Common Stock P - Purchase I 14,0000 1 071 428 15 000 3 659 381
2020-04-17 2020-04-17 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 15,4000 −10 265 −158 298 625
2020-04-17 2020-04-17 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 15,4000 −74 333 −1 145 2 162 587
2020-04-17 2020-04-16 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 15,2000 −3 663 −56 308 890
2020-04-17 2020-04-16 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 15,2000 −26 527 −403 2 236 920
2020-04-17 2020-04-15 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 15,5000 −26 185 −406 312 553
2020-04-17 2020-04-15 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 15,5000 −189 625 −2 939 2 263 447
2020-04-07 2020-04-07 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 14,2000 −742 −11 338 738
2020-04-07 2020-04-07 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 14,2000 −5 373 −76 2 453 072
2020-04-07 2020-04-03 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 13,8000 −36 400 −502 339 480
2020-04-07 2020-04-03 4 Vivo Capital VIII, LLC See footnotes CRNX Common Stock S - Sale I 13,8000 −263 600 −3 638 2 458 445
2020-03-27 3 Madan Ajay CRNX Common Stock D 152 092
2020-03-27 3 Madan Ajay CRNX Common Stock D 152 092
2020-03-27 3 Madan Ajay CRNX Common Stock D 152 092
2020-03-11 2020-03-09 4 Vivo Capital VIII, LLC CRNX Common Stock S - Sale I 19,5000 −133 −3 168 165
2020-03-11 2020-03-09 4 Vivo Capital VIII, LLC CRNX Common Stock S - Sale I 19,5000 −48 −1 375 880
2020-03-11 2020-03-09 4 Vivo Capital VIII, LLC CRNX Common Stock S - Sale I 19,5000 −347 −7 2 722 045
2020-02-26 2020-02-24 4 Wilson Marc CRNX Stock Option (right to buy) A - Award D 22,61 70 000 70 000
2020-02-26 2020-02-24 4 Krasner Alan Seth CRNX Stock Option (right to buy) A - Award D 22,61 45 000 45 000
2020-02-26 2020-02-24 4 Struthers Richard Scott CRNX Stock Option (right to buy) A - Award D 22,61 200 000 200 000
2020-02-11 2019-05-20 5 Wilson Marc CRNX Common Stock J - Other D 14,4500 1 471 21 58 792
2020-02-11 2019-05-20 5 Krasner Alan Seth CRNX Common Stock J - Other D 14,4500 1 471 21 4 941
2020-02-11 2019-08-13 5 Struthers Richard Scott By Family Trust 4 CRNX Common Stock G - Gift I 100 000 100 000
2020-02-11 2019-08-13 5 Struthers Richard Scott By Family Trust 3 CRNX Common Stock G - Gift I 100 000 100 000
2020-02-11 2019-08-13 5 Struthers Richard Scott By Family Trust 2 CRNX Common Stock G - Gift I 100 000 100 000
2020-02-11 2019-08-13 5 Struthers Richard Scott By Family Trust 1 CRNX Common Stock G - Gift I −300 000 925 805
2020-02-11 2020-02-10 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 21,4000 −5 904 −126 168 298
2020-02-11 2020-02-10 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 21,4000 −200 −4 375 928
2020-02-11 2020-02-10 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 21,4000 −1 451 −31 2 722 392
2020-02-11 2020-02-07 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,0000 −4 614 −102 174 202
2020-02-11 2020-02-07 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,0000 −157 −3 376 128
2020-02-11 2020-02-07 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,0000 −1 134 −25 2 723 843
2020-02-06 2020-02-04 4 Vivo Capital VIII, LLC Footnotes CRNX Common Stock S - Sale I 22,8000 −10 519 −240 178 816
2020-02-06 2020-02-04 4 Vivo Capital VIII, LLC Footnotes CRNX Common Stock S - Sale I 22,8000 −357 −8 376 285
2020-02-06 2020-02-04 4 Vivo Capital VIII, LLC Footnotes CRNX Common Stock S - Sale I 22,8000 −2 584 −59 2 724 977
2020-01-31 2020-01-31 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 21,7000 −4 220 −92 189 335
2020-01-31 2020-01-31 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 21,7000 −143 −3 376 642
2020-01-31 2020-01-31 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 21,7000 −1 037 −23 2 727 561
2020-01-31 2020-01-30 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,1000 −5 940 −131 193 555
2020-01-31 2020-01-30 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,1000 −201 −4 376 785
2020-01-31 2020-01-30 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,1000 −1 459 −32 2 728 598
2020-01-31 2020-01-29 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,2000 −10 878 −241 199 495
2020-01-31 2020-01-29 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,2000 −369 −8 376 986
2020-01-31 2020-01-29 4 Vivo Capital VIII, LLC See foonotes CRNX Common Stock S - Sale I 22,2000 −2 673 −59 2 730 057
2019-12-18 2019-12-16 4 Fust Matthew K CRNX Non-qualified stock option (Right to Buy) M - Exercise D 1,91 −3 500 42 092
2019-12-18 2019-12-16 4 Fust Matthew K CRNX Common Stock S - Sale D 22,5000 −3 500 −79 12 536
2019-12-18 2019-12-16 4 Fust Matthew K CRNX Common Stock M - Exercise D 1,9100 3 500 7 16 036
2019-08-07 2019-08-05 4 Struthers Richard Scott CRNX Stock Option (right to buy) M - Exercise D 1,91 −10 000 172 370
2019-08-07 2019-08-05 4 Struthers Richard Scott By Family Trust CRNX Common Stock M - Exercise I 1,9100 10 000 19 1 225 805
2019-08-07 2019-05-08 4 Struthers Richard Scott By Family Trust CRNX Common Stock G - Gift I 1 215 805 1 215 805
2019-08-07 2019-05-08 4 Struthers Richard Scott CRNX Common Stock G - Gift D −1 215 805 0
2019-07-16 2019-07-15 4 Okey Stephanie CRNX Stock Option (right to buy) A - Award D 24,15 25 000 25 000
2019-06-25 2019-06-21 4 5AM Ventures IV, L.P. See footote CRNX Common Stock S - Sale I 22,2000 −10 000 −222 94 489
2019-06-25 2019-06-21 4 5AM Ventures IV, L.P. See footote CRNX Common Stock S - Sale I 22,2000 −240 000 −5 328 2 267 797
2019-06-25 2019-06-21 4 WIERENGA WENDALL CRNX Stock Option (right to buy) A - Award D 23,24 12 500 12 500
2019-06-25 2019-06-21 4 Kaldor Stephen W CRNX Stock Option (right to buy) A - Award D 23,24 12 500 12 500
2019-06-25 2019-06-21 4 Fust Matthew K CRNX Stock Option (right to buy) A - Award D 23,24 12 500 12 500
2019-06-25 2019-06-21 4 Nielsen Jack CRNX Stock Option (right to buy) A - Award D 23,24 12 500 12 500
2019-06-25 2019-06-21 4 Nichols Weston CRNX Stock Option (right to buy) A - Award D 23,24 12 500 12 500
2019-03-25 2019-03-20 4 Vivo Capital VIII, LLC CRNX Common Stock S - Sale I 22,2500 −83 984 −1 869 210 373
2019-03-25 2019-03-20 4 Vivo Capital VIII, LLC CRNX Common Stock S - Sale I 22,2500 −40 407 −899 377 355
2019-03-25 2019-03-20 4 Vivo Capital VIII, LLC CRNX Common Stock S - Sale I 22,2500 −292 609 −6 511 2 732 730
2019-03-20 2019-03-18 4 5AM Ventures IV, L.P. CRNX Common Stock S - Sale I 24,2507 −6 194 −150 104 489
2019-03-20 2019-03-18 4 5AM Ventures IV, L.P. CRNX Common Stock S - Sale I 24,2507 −148 645 −3 605 2 507 797
2019-03-12 2019-03-08 4 Krasner Alan Seth CRNX Stock Option (right to buy) A - Award D 25,19 56 250 56 250
2019-03-12 2019-03-08 4 Wilson Marc CRNX Stock Option (right to buy) A - Award D 25,19 56 250 56 250
2019-03-12 2019-03-08 4 Struthers Richard Scott CRNX Stock Option (right to buy) A - Award D 25,19 176 250 176 250
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 783 1 723
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 783 1 723
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 783 1 723
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 587 940
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 353 353
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 940 940
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 940 940
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I −4 700 0
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. CRNX Common Stock J - Other I 4 700 4 700
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. See foototes CRNX Common Stock J - Other I −18 800 110 683
2019-02-22 2019-02-20 4 5AM Ventures IV, L.P. See foototes CRNX Common Stock J - Other I −451 200 2 656 442
2019-02-12 2018-11-20 5 Krasner Alan Seth CRNX Common Stock J - Other D 14,4500 1 470 21 3 470
2019-02-12 2018-11-20 5 Wilson Marc CRNX Common Stock J - Other D 14,4500 1 470 21 57 321
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I −678 0
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I 678 678
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I −9 473 0
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I 9 473 9 473
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I −33 903 192 122
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I −14 828 84 161
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I −13 387 75 949
2019-02-06 2019-02-04 4 Versant Venture Capital V, L.P. CRNX Common Stock J - Other I −445 470 2 524 456
2019-01-24 2019-01-22 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock S - Sale I 21,8750 −10 486 −229 129 483
2019-01-24 2019-01-22 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock S - Sale I 21,8750 −251 667 −5 505 3 107 642
2018-08-27 2018-07-20 4/A PERCEPTIVE ADVISORS LLC CRNX Series B Preferred Stock C - Conversion I −6 186 205 0
2018-08-27 2018-07-20 4/A PERCEPTIVE ADVISORS LLC See footnotes CRNX Common Stock P - Purchase I 17,0000 400 000 6 800 2 587 953
2018-08-27 2018-07-20 4/A PERCEPTIVE ADVISORS LLC See footnotes CRNX Common Stock C - Conversion I 1 880 305 2 187 953
2018-08-27 2018-07-18 4/A PERCEPTIVE ADVISORS LLC See footnotes CRNX Common Stock P - Purchase I 21,3000 307 648 6 553 307 648
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Series B Preferred Stock C - Conversion I −61 861 0
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Series A Preferred Stock C - Conversion I −383 507 0
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Series B Preferred Stock C - Conversion I −1 484 690 0
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Series A Preferred Stock C - Conversion I −9 204 220 0
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock P - Purchase I 17,0000 4 600 78 139 969
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock P - Purchase I 17,0000 110 400 1 877 3 359 309
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock C - Conversion I 18 802 135 369
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock C - Conversion I 116 567 116 567
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock C - Conversion I 451 274 3 248 909
2018-07-20 2018-07-20 4 5AM Ventures IV, L.P. See footnotes CRNX Common Stock C - Conversion I 2 797 635 2 797 635
2018-07-20 2018-07-20 4 PERCEPTIVE ADVISORS LLC CRNX Series B Preferred Stock C - Conversion I −6 186 205 0
2018-07-20 2018-07-20 4 PERCEPTIVE ADVISORS LLC CRNX Common Stock P - Purchase I 17,0000 400 000 6 800 2 280 305
2018-07-20 2018-07-20 4 PERCEPTIVE ADVISORS LLC CRNX Common Stock C - Conversion I 1 880 305 1 880 305
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Series B Preferred Stock C - Conversion I −187 648 0
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Series B Preferred Stock C - Conversion I −1 358 903 0
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Series A Preferred Stock C - Conversion I −1 163 311 0
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Series A Preferred Stock C - Conversion I −8 424 416 0
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock P - Purchase I 20,7300 153 180 3 175 294 357
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock P - Purchase I 17,0000 141 177 2 400 141 177
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock P - Purchase I 17,0000 7 137 121 417 762
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock P - Purchase I 17,0000 51 686 879 3 025 339
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock C - Conversion I 57 035 410 625
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock C - Conversion I 413 040 2 973 653
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock C - Conversion I 353 590 353 590
2018-07-20 2018-07-20 4 Vivo Capital VIII, LLC CRNX Common Stock C - Conversion I 2 560 613 2 560 613
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series B Preferred Stock C - Conversion I −103 293 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series B Preferred Stock C - Conversion I −45 192 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series B Preferred Stock C - Conversion I −40 826 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series B Preferred Stock C - Conversion I −1 357 240 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series A Preferred Stock C - Conversion I −640 332 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series A Preferred Stock C - Conversion I −280 485 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series A Preferred Stock C - Conversion I −253 091 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Series A Preferred Stock C - Conversion I −8 413 817 0
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 31 396 226 025
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 13 736 98 989
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 12 409 89 336
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 412 534 2 969 926
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 194 629 194 629
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 85 253 85 253
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 76 927 76 927
2018-07-20 2018-07-20 4 Versant Venture Capital V, L.P. See Footnotes CRNX Common Stock C - Conversion I 2 557 392 2 557 392
2018-07-20 2018-07-20 4 Krasner Alan Seth CRNX Common Stock P - Purchase D 17,0000 2 000 34 2 000
2018-07-17 3 Struthers Richard Scott CRNX Common Stock D 2 431 610
2018-07-17 3 Struthers Richard Scott CRNX Common Stock D 2 431 610
2018-07-17 3 Struthers Richard Scott CRNX Common Stock D 2 431 610
2018-07-17 3 Wilson Marc CRNX Common Stock D 111 702
2018-07-17 3 Wilson Marc CRNX Common Stock D 111 702
2018-07-17 3 Wilson Marc CRNX Common Stock D 111 702
2018-07-17 3 Fust Matthew K CRNX Common Stock D 25 072
2018-07-17 3 Fust Matthew K CRNX Common Stock D 25 072
2018-07-17 3 Fust Matthew K CRNX Common Stock D 25 072
2018-07-17 3 WIERENGA WENDALL CRNX Common Stock D 149 034
2018-07-17 3 WIERENGA WENDALL CRNX Common Stock D 149 034
2018-07-17 3 WIERENGA WENDALL CRNX Common Stock D 149 034
2018-07-17 3 Vivo Capital Surplus Fund VIII, L.P. By Vivo Capital, LLC CRNX Common Stock I 109 422
2018-07-17 3 Vivo Capital Surplus Fund VIII, L.P. By Vivo Capital, LLC CRNX Common Stock I 109 422
2018-07-17 3 Vivo Capital Surplus Fund VIII, L.P. By Vivo Capital, LLC CRNX Common Stock I 109 422
2018-07-17 3 Vivo Capital Surplus Fund VIII, L.P. By Vivo Capital, LLC CRNX Common Stock I 109 422
2018-07-17 3 Vivo Capital Surplus Fund VIII, L.P. By Vivo Capital, LLC CRNX Common Stock I 109 422
2018-07-17 3 Vivo Capital Surplus Fund VIII, L.P. By Vivo Capital, LLC CRNX Common Stock I 109 422
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Other Listings
DE:6Z4 29,20 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista